TSX:AH - Toronto Stock Exchange - CA01444Q1046 - Common Stock - Currency: CAD
TSX:AH (7/25/2023, 7:00:00 PM)
0.02
0 (0%)
The current stock price of AH.CA is 0.02 CAD. In the past month the price decreased by -20%. In the past year, price decreased by -71.43%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
BHC.CA | BAUSCH HEALTH COS INC | 1.64 | 3.13B | ||
CRON.CA | CRONOS GROUP INC | 14.28 | 990.50M | ||
DHT-UN.CA | DRI HEALTHCARE TRUST | 6.33 | 759.62M | ||
GUD.CA | KNIGHT THERAPEUTICS INC | 53.18 | 582.84M | ||
TLRY.CA | TILRAY BRANDS INC | N/A | 523.02M | ||
WEED.CA | CANOPY GROWTH CORP | N/A | 361.42M | ||
CPH.CA | CIPHER PHARMACEUTICALS INC | 26.04 | 326.91M | ||
ACB.CA | AURORA CANNABIS INC | 9.47 | 306.67M | ||
NGEN.CA | NERVGEN PHARMA CORP | N/A | 273.98M | ||
HITI.CA | HIGH TIDE INC | N/A | 247.98M | ||
OGI.CA | ORGANIGRAM GLOBAL INC | 29.33 | 235.63M | ||
HLS.CA | HLS THERAPEUTICS INC | N/A | 156.88M |
Aleafia Health, Inc. engages in the provision of healthcare services, which focuses on medical cannabis healthcare solutions. The company is headquartered in Concord, Ontario and currently employs 158 full-time employees. The company went IPO on 2011-07-29. The firm offers cannabis products in Canada and destined for international markets, including Australia and Germany. The firm operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. The company owns three licensed cannabis production facilities and operates a located distribution center all in the province of Ontario, including an outdoor cannabis cultivation facility in Canada. The firm produces a diverse portfolio of cannabis and cannabis derivative products, including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips, and topicals, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions. Its subsidiaries include Aleafia Inc., Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and other.
Aleafia Health Inc
85 Basaltic Road
Concord ONTARIO L4K 1G4 CA
CEO: Geoffrey M. Benic
Employees: 158
Phone: 19024054600.0
The current stock price of AH.CA is 0.02 CAD.
The exchange symbol of Aleafia Health Inc is AH and it is listed on the Toronto Stock Exchange exchange.
AH.CA stock is listed on the Toronto Stock Exchange exchange.
8 analysts have analysed AH.CA and the average price target is 0.15 CAD. This implies a price increase of 665% is expected in the next year compared to the current price of 0.02. Check the Aleafia Health Inc stock analysts ratings, price target forecast and up-and down grades for more detailed information.
Aleafia Health Inc (AH.CA) has a market capitalization of 8.06M CAD. This makes AH.CA a Nano Cap stock.
Aleafia Health Inc (AH.CA) currently has 158 employees.
The Revenue of Aleafia Health Inc (AH.CA) is expected to grow by 51.58% in the next year. Check the estimates tab for more information on the AH.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AH.CA does not pay a dividend.
Aleafia Health Inc (AH.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.1).
ChartMill assigns a fundamental rating of 2 / 10 to AH.CA. AH.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months AH.CA reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 79.4% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 40% to AH.CA. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 40% and a revenue growth 51.58% for AH.CA